Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Categories
  3. Pain Management

Pain Management Research

Browse the latest research summaries in the field of pain management for spinal cord injury patients and caregivers.

Showing 651-660 of 682 results

Spinal Cord InjuryNeurologyPain Management

Adult spinal cord neurogenesis: A regulator of nociception

NEUROGENESIS, 2016 • November 1, 2016

Adult spinal cord neurogenesis is a process where new neurons are generated in the spinal cord, influencing pain sensitivity. Under normal conditions, it helps maintain a stable level of pain sensitiv...

KEY FINDING: Adult spinal cord neurogenesis contributes to maintaining a steady-state level of nociceptive sensitivity under normal conditions.

Read Summary
EndocrinologyNeurologyPain Management

Estrogen affects neuropathic pain through upregulating N-methyl-D-aspartate acid receptor 1 expression in the dorsal root ganglion of rats

Neural Regeneration Research, 2017 • March 1, 2017

The study aimed to determine whether a relationship exists between estrogen and NMDAR1 in peripheral nerve pain using a rat model of chronic sciatic nerve constriction injury. Rats administered estrad...

KEY FINDING: Estrogen administration significantly reduced mechanical and thermal pain thresholds in rats with chronic constriction of the sciatic nerve.

Read Summary
Spinal Cord InjuryRegenerative MedicinePain Management

RGMa inhibition with human monoclonal antibodies promotes regeneration, plasticity and repair, and attenuates neuropathic pain after spinal cord injury

Scientific Reports, 2017 • August 17, 2017

This study investigates the therapeutic potential of human anti-RGMa antibodies in treating spinal cord injury (SCI) by promoting regeneration and reducing neuropathic pain. The research demonstrates ...

KEY FINDING: RGMa is significantly upregulated in multiple cell types following impact-compression SCI in rats and in the injured human spinal cord.

Read Summary
Spinal Cord InjuryNeurologyPain Management

Data on the expression of leptin and leptin receptor in the dorsal root ganglion and spinal cord after preganglionic cervical root avulsion

Data in Brief, 2017 • October 7, 2017

This data article presents findings on the expression patterns of leptin (Lep) and its receptor (LepR) in the dorsal root ganglion (DRG) and spinal cord following preganglionic cervical root avulsion ...

KEY FINDING: Generalized expression of Lep and LepR was noted 7 days after PCRA in DRG neurons.

Read Summary
PharmacologyRegenerative MedicinePain Management

Long-Chain Omega-3 Fatty Acids Supplementation Accelerates Nerve Regeneration and Prevents Neuropathic Pain Behavior in Mice

Frontiers in Pharmacology, 2017 • October 17, 2017

This work demonstrates the effect of combined long-chain omega-3 fatty acids (CFO), EPA and DHA, in nerve regeneration and prevention of NP in mice, shedding light on its mechanism of action. Our resul...

KEY FINDING: CFO at 2.3 g/kg significantly prevented mechanical allodynia and reduced thermal hypernociception in mice compared to animals receiving vehicle only.

Read Summary
PharmacologyNeurologyPain Management

Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model

Toxins, 2018 • March 18, 2018

This study aimed to verify if BoNT/B is able to counteract neuropathic pain, and to interfere with inflammatory and regenerative processes associated with nerve injury. The results of this study show ...

KEY FINDING: BoNT/B reduces neuropathic pain over a long period of time, similar to BoNT/A.

Read Summary
Regenerative MedicineNeurologyPain Management

Attenuation of TRPV1 by AMG-517 after nerve injury promotes peripheral axonal regeneration in rats

Molecular Pain, 2018 • April 10, 2018

This study investigated the effects of blocking TRPV1 with AMG-517 on nerve regeneration after sciatic nerve injury in rats. The results showed that AMG-517 promoted axonal regeneration, decreased gli...

KEY FINDING: Blockage of TRPV1 with AMG-517 markedly promoted axonal regeneration, especially at two weeks after sciatic injury.

Read Summary
NeurologyPain ManagementOrthopedics

Percutaneous direct current stimulation – a new electroceutical solution for severe neurological pain and soft tissue injuries

Medical Devices: Evidence and Research, 2018 • January 1, 2018

The study introduces a novel electroceutical device that delivers percutaneous direct current (DC) stimulation to treat severe neurological pain and soft tissue injuries. The device mimics and modulat...

KEY FINDING: Percutaneous DC stimulation significantly reduced pain and attack frequency in a patient with chronic cluster headaches, leading to complete remission for over 3 years.

Read Summary
PharmacologyRheumatologyPain Management

Analgesic effects of ASP3662, a novel 11β-hydroxysteroid dehydrogenase 1 inhibitor, in rat models of neuropathic and dysfunctional pain

British Journal of Pharmacology, 2018 • January 1, 2018

This study investigates the analgesic effects of ASP3662, a novel 11β-HSD1 inhibitor, in rat models of neuropathic and dysfunctional pain. ASP3662 is a potent, selective, and CNS-penetrable inhibitor ...

KEY FINDING: ASP3662 effectively inhibits 11β-HSD1 in humans, mice, and rats, demonstrating selectivity over 11β-HSD2 and showing no significant impact on other enzymes, transporters, and receptors.

Read Summary
OncologyPain ManagementGenetics

Analgesic effect of AG490, a Janus kinase inhibitor, on oxaliplatin-induced acute neuropathic pain

Neural Regen Res, 2018 • June 1, 2018

This study investigates the analgesic effect of AG490 on oxaliplatin-induced acute neuropathic pain in rats. The findings demonstrate that AG490 attenuates oxaliplatin-induced acute neuropathic pain b...

KEY FINDING: AG490 treatment significantly increased paw withdrawal threshold and tail withdrawal latency in rats with oxaliplatin-induced neuropathic pain, indicating reduced sensitivity to mechanical and cold stimuli.

Read Summary
Previous
1...656667...69
Next